U.S. Healthtech Stock News

Rocket Companies, Inc. reported past first-quarter 2026 results with revenue rising to US$2.94 billion from US$1.10 billion a year earlier, swinging from a US$10 million net loss to US$297 million in net income and returning to positive earnings per share. Management linked this performance to over US$500 million of AI investment, faster-than-planned integration of Mr. Cooper and Redfin, and a shift toward recurring or less rate-sensitive revenue streams that now account for roughly 70% of...

Newell Brands (NWL) is drawing fresh attention after unveiling a Toy Story 5 themed Sharpie and Elmer’s collection with Disney and Pixar, a marketing driven collaboration that could influence how investors view the stock. See our latest analysis for Newell Brands. The Toy Story 5 collaboration lands after a volatile stretch, with a 30 day share price return of 25% and a year to date share price gain of 19.62%. This is set against a 1 year total shareholder return decline of 10.18%, which...

Synaptics recently reported third-quarter fiscal 2026 results, with revenue rising to US$294.2 million from US$266.6 million a year earlier, while its net loss narrowed to US$8.0 million from US$21.8 million. Beneath the headline numbers, management emphasized rapidly growing Core IoT sales, expanding Physical AI and Edge AI design wins, and a deepening collaboration with Google on next-generation AI hardware platforms. Next, we’ll explore how the strong Core IoT growth and Physical AI...

Key recent performance and business mix Stewart Information Services (STC) has seen mixed share price moves recently, with a gain over the past month alongside a small decline over the past 3 months and year to date. The stock’s past year total return of 11.5% contrasts with a modest loss over the past 3 years. Over 5 years, the total return stands at 35.96%, giving investors a varied performance profile to assess. On the fundamentals side, the company reports annual revenue of US$3.10b and...

In the past quarter, Roper Technologies reported Q1 2026 adjusted DEPS of US$5.16, 11.3% revenue growth, raised its full-year profit outlook, and arranged a US$3.50 billion revolving credit facility to support future acquisitions. A key takeaway is that AI-driven demand across Roper’s software portfolio is becoming a central earnings driver while the larger credit line enhances financial flexibility for further portfolio expansion. We’ll now examine how Roper’s raised profit outlook,...

ACADIA Pharmaceuticals (ACAD) is back in focus after first quarter 2026 results showed 10% year over year revenue growth to US$268.1 million, alongside weaker earnings, higher expenses, and a setback for trofinetide in Europe. See our latest analysis for ACADIA Pharmaceuticals. The mixed Q1 2026 update, together with the negative EU opinion on trofinetide and leadership changes in research and development, appears to be feeding into a share price that has struggled year to date despite a...

Xeris Biopharma Holdings (XERS) stock is in focus after the company reported a profitable first quarter of 2026 and raised its full year revenue guidance to US$380 million to US$390 million. See our latest analysis for Xeris Biopharma Holdings. The guidance hike and first quarter profit have come after a mixed period for the stock, with a 12.95% 1 month share price return and a 9.80% year to date share price decline. At the same time, 1 year and 3 year total shareholder returns of 28.49% and...

IES Holdings (IESC) shares have been moving after the company reported second quarter 2026 earnings, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for IES Holdings. The earnings release and the recent agreement to acquire Broadwind's Abilene facility have come alongside strong share price momentum, with a 30 day share price return of 38.13% and a 1 year total shareholder return of 165.60%. Multi year total...

Sotera Health (SHC) just delivered a busy first quarter, pairing 10% year-over-year revenue growth and a move back to profitability with reaffirmed 2026 guidance and a planned CEO transition. See our latest analysis for Sotera Health. The share price is US$15.67 after a 7.04% 1 month share price return. However, the 90 day share price return of 11.72% and year to date share price return of 11.42% suggest recent momentum has cooled. Even so, the 1 year total shareholder return of 18.44% and 3...

Permian Resources (PR) is back in focus after recent share price moves, with the stock now around US$20.08. Investors are weighing its latest returns, revenue profile and intrinsic value signals. See our latest analysis for Permian Resources. While the share price has pulled back recently, with a 1-day share price return of 5.33% and a 7-day share price return of 7.12%, momentum over longer periods remains strong. This includes a 39.44% year to date share price return and a very strong 5-year...

In recent weeks, Tesla has reported a rebound in China-made EV sales, secured its largest-ever Semi truck order from WattEV worth about US$100 million, posted stronger quarterly earnings with margin recovery, and advanced major AI, robotaxi and chip initiatives including the Terafab semiconductor project in Texas. Taken together with the Model Y clearing new US safety evaluations and ongoing robotaxi pilots, these developments underscore Tesla’s push to reposition itself as a vertically...

Earnings beat and guidance reset the conversation for Carter's stock Carter's (CRI) stock is back in focus after first quarter 2026 results came in ahead of analyst expectations on both revenue and profit, along with Q2 and full year guidance that surprised positively. See our latest analysis for Carter's. At a share price of $35.75, Carter's has a year to date share price return of 7.68%, while the 1 year total shareholder return stands at 7.31%. This is set against a weaker 3 year and 5...

Event context and recent share performance Payoneer Global (PAYO) has drawn attention after a period of mixed share performance, with the stock up about 4.1% over the past day and 5.2% over the past month, but showing a 20.1% decline over the past 3 months. See our latest analysis for Payoneer Global. That recent 1-day share price return of 4.1% and 30-day share price return of 5.2% sit against a weaker backdrop, with a 90-day share price return showing a 20.1% decline and a 1-year total...

Why DexCom's latest earnings matter for investors DexCom (DXCM) just reported first quarter 2026 results, with revenue of US$1.192b and net income of US$199.5m, alongside higher margins and updated profitability guidance that put cash generation and product momentum in focus. See our latest analysis for DexCom. Despite the strong first quarter update and profitability guidance, DexCom's recent share price performance has been weak. The 90 day share price return shows a 12.95% decline and the...

Nuvalent (NUVL) is in focus after a cluster of company updates, including first quarter earnings that showed a net loss of US$109.28 million and new detail on late stage oncology milestones. See our latest analysis for Nuvalent. At a share price of US$102.40, Nuvalent has seen mixed short term moves, with a 1 day share price return of 1.78% decline but a 1 year total shareholder return of 43.02%. This points to stronger momentum over a longer window as investors weigh the NDA progress,...

In the first quarter of 2026, Beam Therapeutics reported a net loss of US$94.32 million (US$0.91 per share) alongside a very large year-over-year revenue increase to US$31.74 million, largely driven by collaboration milestones. At the same time, Beam advanced its base-editing pipeline with positive BEAM-302 and risto-cel data, outlined plans for a potential accelerated path to approval in multiple rare diseases, and reinforced its liquidity with US$1.20 billion in cash and a new US$100...

Recently, Vail Resorts benefited from a sharp fall in crude oil prices tied to optimism about reopening the Strait of Hormuz, which could ease fuel-related cost pressures across the travel and leisure sector. An insider equity vesting by executive Julie A. DeCecco also occurred in early May, highlighting ongoing equity-based compensation alignment between management and shareholders. Next, we’ll examine how lower oil-related operating costs might influence Vail Resorts’ existing investment...

Lemonade (LMND) has expanded its renters insurance into New Hampshire and West Virginia, extending its digital, app based coverage to more U.S. renters and putting the stock back on many investors’ radar. See our latest analysis for Lemonade. The renters expansion arrives after a busy few weeks, including first quarter results on 29 April that showed revenue of US$258 million and a net loss of US$35.8 million. This came alongside a 1 year total shareholder return of 74.34% contrasted with a...

Align Technology (ALGN) is back in focus after its Q1 2026 earnings release, reaffirmed guidance, and a fresh wave of clear aligner and digital workflow product updates previewed at the AAO 2026 orthodontics conference. See our latest analysis for Align Technology. Despite the Q1 2026 earnings beat, reaffirmed guidance, and product updates previewed around AAO 2026, the stock’s 1-day share price return of 3.19% decline and 7-day share price return of 4.33% decline suggest some near term...

Event context and recent share performance Public Service Enterprise Group (PEG) stock has been moving lower recently, with a 1.9% decline over the past day and negative returns over the past week, month and past 3 months drawing fresh attention from investors. See our latest analysis for Public Service Enterprise Group. Zooming out from the latest pullback, the stock’s recent negative share price returns contrast with a positive 1-year total shareholder return of 1.1% and stronger multi year...

MoonLake Immunotherapeutics recently reported a positive final pre-BLA meeting with the U.S. FDA for sonelokimab in hidradenitis suppurativa, securing alignment on submission timing, label strategy including adolescent data, and a planned BLA filing by the end of September 2026 supported by US$357.9 million in cash and access to up to US$400 million in non-dilutive debt. An interesting aspect for investors is the potential for FDA Priority Review and a first U.S. commercial launch target in...

Inflation jitters, higher energy costs and uneven global growth are putting a spotlight on company quality. When price pressures, shifting trade flows and rate expectations keep markets on edge, stocks with high return on equity, solid past performance and strong balance sheets can offer a more direct way to focus on business strength rather than noise. This article uses our Solid Balance Sheet and Fundamentals screener to highlight 3 stocks that fit this quality filter, helping you focus on...

In late April and early May 2026, Amazon reported strong first-quarter results, with revenue of US$181.52 billion and net income of US$30.26 billion, and also launched Amazon Supply Chain Services to offer its full freight, distribution, fulfillment, and parcel shipping network to third-party businesses across multiple industries. This move effectively turns Amazon’s in-house logistics engine into a standalone service business, extending its reach beyond retail and deepening its presence in...

Q1 results and new Defense Logistics Agency contract draw investor focus Perimeter Solutions (PRM) is in focus after reporting Q1 2026 sales of US$125.07 million and net income of US$72.94 million, along with securing a US$500 million Defense Logistics Agency contract. See our latest analysis for Perimeter Solutions. The stock has been volatile around these updates, with a 7.11% 1 day share price return and a 21.52% 30 day share price return. The 1 year total shareholder return is very large,...